Photo credit: Garrett James Photography
The BC Hockey League (BCHL) has announced a partnership with HealthTech Connex (HTC) to enable all BCHL players access to their innovative brain health assessment technology.
Founded and headquartered in Surrey, B.C., HTC has developed the NeuroCatch® Platform (NeuroCatch®) that enables access to an objective assessment of brain health at the point of care, in minutes. NeuroCatch® uses a portable electroencephalogram (EEG) technology to measure neurophysiological markers of cognition in the brain, called brain vital signs.
“We are pleased to be working alongside HTC to give our players the opportunity to use their state-of-the-art NeuroCatch® technology,” said BCHL Deputy Commissioner and Chief Operating Officer Steven Cocker. “The health and well-being of our athletes is of the utmost importance to the BCHL and our 18 teams.”
In addition to sensitive brain function results being highly important in safe return to play, the data from NeuroCatch® scans can also help athletes optimize their performance by working on and monitoring their cognitive abilities.
“Our mission is to positively impact a billion brains, and it was an easy decision to work with the top Junior A hockey league, which happens to be in our backyard,” said Dr. Ryan D’Arcy, HTC’s President and Chief Scientific Officer. “Not only is it extremely important to have an objective evaluation of brain health when making a decision to return an injured player back onto the ice, but our technology also allows us to repeatedly scan players throughout the course of a season, and their career, to monitor for any significant changes in their brain function.”
For more information on HealthTech Connex, visit www.healthtechconnex.com or www.neurocatch.com.
